Status:
TERMINATED
The Patency Period of the New Plastic Anti-reflux Biliary Stent
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Pancreatitis
Cholangitis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The aim of this study is to determine the average patency period of the new anti-reflux biliary stent on patients with malignant bile duct strictures and to determine if this stent remains patent for ...
Detailed Description
Bile duct related cancer is a condition quite commonly seen among Asians. Predisposing conditions for primary bile duct cancer include recurrent infections and autoimmune diseases such as recurrent py...
Eligibility Criteria
Inclusion
- Age 18 years old
- Patients who have cholangiographic evidence (on ERCP) consistent with a malignant extrahepatic biliary stricture (below bifurcation of the common hepatic duct) who require plastic stenting
- Patients with peri-ampullary tumours, pancreatic tumours, gall bladder cancer and metastatic tumours with suspected extrinsic bile duct compression
- Patients with stent or nasobiliary drain in-situ without previous sphincterotomy will qualify for the study if they satisfy the above inclusion criteria.
Exclusion
- Patients fit for surgery.
- Patients who have dominant biliary strictures involving the hilum or more proximal biliary segments.
- Previous sphincterotomy.
- Other medical conditions that will result in a life expectancy of less then 3 months (ASA class \>4)
- Pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01142921
Start Date
November 1 2008
End Date
August 1 2011
Last Update
April 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endoscopy Centre
Hong Kong, China